2022
Cited by 7
In this study, we evaluate the feasibility of using a combination of L-selectin and RAGE for the molecular imaging of PCa.
by C-C. Tsai and S. W. Weng
2022
Cited by 9
C-C Tsai and S. W. Weng. Molecular imaging of prostate cancer with a combination of L-selectin and RAGE. Molecular Imaging. 20:44.
2022
Cited by 10
We hypothesize that radiolabeling of DOTA-PE20-Fab′ with 18F and subsequent binding to PSMA will lead to increased tumor uptake in preclinical models of prostate cancer.
by A. Ziegler et al.
2022
Cited by 11
...DOTA-PE20-Fab is a promising PSMA targeting agent for PET-imaging.
by A. Ziegler et al.
2023
Cited by 13
...PSMA-tethering of DOTA-PE20-Fab [14] increases selective cell binding and uptake.
by A. Ziegler et al.
2023
Cited by 14
...The PET imaging of PSMA-positive LNCaP tumor-bearing mice with 68Ga-DOTA-PE20-Fab showed high tumor-to-organ ratios, enabling clear tumor visualization.
by A. Ziegler et al.
2023
Cited by 17
...The fusion protein consisting of the DOTA-PE20-Fab and PSMA produced by a two-step protein synthesis protocol clearly binds to the tumor cells overexpressing PSMA and offers a promising new targeting molecule for imaging and therapy of prostate cancer.
by A. Ziegler et al.
2023
Cited by 18
...PAMAM dendrimers are promising targeted vehicles for MRI and radionuclide imaging, but the use of PAMAM-based agents with other radionuclides than 68Ga needs to be tested.
by M. Hammer et al.
2023
Cited by 19
...Higher tumour uptake of the radiolabelled G3-PAMAM than of the G2-PAMAM indicates that the number of positive charges on the outermost PAMAM ac619d1d87
Related links: